Uquifa Overview
- Year Founded
-
1936
- Status
-
Acquired/Merged
- Employees
-
329
- Latest Deal Type
-
Debt
- Financing Rounds
-
5
- Investments
-
1
Uquifa General Information
Description
Manufacturer of active pharmaceutical ingredients and intermediates intended to serve pharmaceutical and animal health industries globally. The company offers has an active pharmaceutical ingredients and pipeline portfolio and provides other specialties and CDMO services.
Contact Information
Website
www.uquifa.com(Operating Subsidiary)
Corporate Office
- C/Mallorca 262
- 3rd floor
- 08008 Barcelona
- Spain
Corporate Office
- C/Mallorca 262
- 3rd floor
- 08008 Barcelona
- Spain
Uquifa Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Uquifa Patents
Uquifa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2163547-A1 | Process for the preparation of an oxazolidinone antibacterial agent and intermediates thereof | Inactive | 16-Sep-2008 | 0000000000 | 0 |
| ES-2291135-B1 | Procedure for the preparation of tartrate of (r) -tolterodine. | Inactive | 04-Jul-2006 | 0000000000 | |
| ES-2291135-A1 | Method for the preparation of (r)-tolterodine tartrate | Active | 04-Jul-2006 | 0000000000 | 0 |
| DE-602006006352-D1 | Process for preparing the (s) -enantiomer of omeprazole | Active | 28-Dec-2005 | 0000000000 | |
| ES-2325336-T3 | Procedure for the preparation of omeprazol's enantiom (s). | Active | 28-Dec-2005 | C07D401/12 |
Uquifa Executive Team (6)
| Name | Title | Board Seat |
|---|---|---|
| Saurabh Gurnurkar | Managing Director, Corporate Development and Strategy, Chief Executive Officer and Board Member | |
| Pilar Valle | Chief Financial Officer |
Uquifa Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 00000000 | Self | Board Member | 000 0000 |
| 0000000 00000000 | Vivimed Labs | Board Member | 000 0000 |
| 00000 000000 00 | OrbiMed | Board Member | 000 0000 |
Uquifa Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Uquifa Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Uquifa Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Soneas Chemicals | 01-May-2018 | 0000000000 | 000.00 | Laboratory Services (Healthcare) | 0000000 0 |
Uquifa Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Soneas Chemicals | Laboratory Services (Healthcare) | Budapest, Hungary | 0000 |
Uquifa FAQs
-
When was Uquifa founded?
Uquifa was founded in 1936.
-
Who is the CEO of Uquifa?
Saurabh Gurnurkar is the CEO of Uquifa.
-
Where is Uquifa headquartered?
Uquifa is headquartered in Barcelona, Spain.
-
What is the size of Uquifa?
Uquifa has 329 total employees.
-
What industry is Uquifa in?
Uquifa’s primary industry is Pharmaceuticals.
-
Is Uquifa a private or public company?
Uquifa is a Private company.
-
What is Uquifa’s current revenue?
The current revenue for Uquifa is 00000.
-
How much funding has Uquifa raised over time?
Uquifa has raised $81.5M.
-
Who are Uquifa’s investors?
Holliday Chemical Holdings, InvAscent, and TR Capital have invested in Uquifa.
-
Who acquired Uquifa?
Uquifa was acquired by Vivimed Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
